Hologic, Inc. (HOLX) EV/Assets Ratio: 1.91x
Is Hologic, Inc.’s EV/Assets ratio high or low?
Hologic, Inc.'s EV/Assets ratio of 1.91x is in line with its 5-year average of 2.08x, near the low end of its 5-year range (1.52x–2.91x).
The EV/Assets ratio for Hologic, Inc. (HOLX) is 1.91x as of Wednesday, June 10, 2026. It is above its 12-month average by 3.57% (1.84x).
HOLX EV/Assets Ratio Chart
HOLX Average EV/Assets Ratio Chart
HOLX Current vs Average EV/Assets Ratio Chart
HOLX EV/Assets Ratio Metrics
EV/ASSETS RATIO
1.91x
EV/ASSETS RATIO AVG TTM
1.84x
EV/ASSETS RATIO AVG 3Y
1.98x
EV/ASSETS RATIO AVG 5Y
2.08x
EV/ASSETS RATIO AVG 10Y
2.12x
EV/ASSETS RATIO AVG 15Y
1.82x
EV/ASSETS RATIO AVG 20Y
1.90x
CURRENT VS TTM AVG
+3.57%
CURRENT VS 3Y AVG
-3.55%
CURRENT VS 5Y AVG
-8.36%
CURRENT VS 10Y AVG
-10.02%
CURRENT VS 15Y AVG
+5.05%
CURRENT VS 20Y AVG
+0.56%
HOLX Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hologic, Inc. (HOLX) | $16.97B | 1.91x | 1.84x | 1.98x | 2.08x |
| Moderna, Inc. (MRNA) | $18.40B | 1.55x | 1.14x | 1.48x | 2.53x |
| Align Technology, Inc. (ALGN) | $12.56B | 1.84x | 1.76x | 2.56x | 3.77x |
| BioNTech SE (BNTX) | $21.81B | 0.44x | 0.55x | 0.54x | 1.39x |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 6.85x | 8.27x | 8.63x | 9.33x |
| Baxter International Inc. (BAX) | $10.49B | 0.91x | 0.91x | 1.05x | 1.32x |
| Waters Corporation (WAT) | $23.83B | 1.43x | 4.12x | 4.55x | 5.47x |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 1.56x | 1.50x | 1.60x | 1.95x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.89B | 0.89x | 0.88x | 0.89x | 0.99x |
| Veeva Systems Inc. (VEEV) | $26.73B | 2.78x | 4.63x | 5.33x | 6.99x |
Hologic, Inc. EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hologic, Inc. EV/Assets Ratio FAQ
- What is the EV/Assets ratio for Hologic, Inc. (HOLX)?
- The EV/Assets ratio for HOLX stock is 1.91x.
- Is Hologic, Inc.'s EV/Assets ratio high or low?
- Hologic, Inc.'s EV/Assets ratio of 1.91x is in line with its 5-year average of 2.08x, near the low end of its 5-year range (1.52x–2.91x).
- What is the TTM average EV/Assets ratio for Hologic, Inc. (HOLX)?
- The TTM average EV/Assets ratio for HOLX stock is 1.84x.
- What is the 3Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
- The 3Y average EV/Assets ratio for HOLX stock is 1.98x.
- What is the 5Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
- The 5Y average EV/Assets ratio for HOLX stock is 2.08x.
- What is the 10Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
- The 10Y average EV/Assets ratio for HOLX stock is 2.12x.
- What is the 15Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
- The 15Y average EV/Assets ratio for HOLX stock is 1.82x.
- What is the 20Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
- The 20Y average EV/Assets ratio for HOLX stock is 1.90x.
Hologic, Inc. EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-04-07 | 1.91x |
| 2026-04-06 | 1.91x |
| 2026-04-02 | 1.90x |
| 2026-04-01 | 1.90x |
| 2026-03-31 | 1.90x |
| 2026-03-30 | 1.90x |
| 2026-03-27 | 1.90x |
| 2026-03-26 | 1.90x |
| 2026-03-25 | 1.90x |
| 2026-03-24 | 1.90x |
| 2026-03-23 | 1.90x |
| 2026-03-20 | 1.89x |
| 2026-03-19 | 1.89x |
| 2026-03-18 | 1.89x |
| 2026-03-17 | 1.88x |
| 2026-03-16 | 1.89x |
| 2026-03-13 | 1.89x |
| 2026-03-12 | 1.89x |
| 2026-03-11 | 1.89x |
| 2026-03-10 | 1.90x |
| 2026-03-09 | 1.90x |
| 2026-03-06 | 1.90x |
| 2026-03-05 | 1.90x |
| 2026-03-04 | 1.90x |
| 2026-03-03 | 1.89x |
| 2026-03-02 | 1.89x |
| 2026-02-27 | 1.89x |
| 2026-02-26 | 1.89x |
| 2026-02-25 | 1.89x |
| 2026-02-24 | 1.89x |
| 2026-02-23 | 1.89x |
| 2026-02-20 | 1.89x |
| 2026-02-19 | 1.89x |
| 2026-02-18 | 1.89x |
| 2026-02-17 | 1.89x |
| 2026-02-13 | 1.88x |
| 2026-02-12 | 1.88x |
| 2026-02-11 | 1.89x |
| 2026-02-10 | 1.89x |
| 2026-02-09 | 1.88x |
| 2026-02-06 | 1.88x |
| 2026-02-05 | 1.88x |
| 2026-02-04 | 1.87x |
| 2026-02-03 | 1.87x |
| 2026-02-02 | 1.88x |
| 2026-01-30 | 1.88x |
| 2026-01-29 | 1.88x |
| 2026-01-28 | 1.95x |
| 2026-01-27 | 1.96x |
| 2026-01-26 | 1.96x |
| 2026-01-23 | 1.95x |
| 2026-01-22 | 1.95x |
| 2026-01-21 | 1.96x |
| 2026-01-20 | 1.95x |
| 2026-01-16 | 1.95x |
| 2026-01-15 | 1.95x |
| 2026-01-14 | 1.96x |
| 2026-01-13 | 1.95x |
| 2026-01-12 | 1.95x |
| 2026-01-09 | 1.95x |
| 2026-01-08 | 1.95x |
| 2026-01-07 | 1.95x |
| 2026-01-06 | 1.95x |
| 2026-01-05 | 1.95x |
| 2026-01-02 | 1.94x |
| 2025-12-31 | 1.94x |
| 2025-12-30 | 1.94x |
| 2025-12-29 | 1.94x |
| 2025-12-26 | 1.94x |
| 2025-12-24 | 1.94x |
| 2025-12-23 | 1.95x |
| 2025-12-22 | 1.95x |
| 2025-12-19 | 1.95x |
| 2025-12-18 | 1.95x |
| 2025-12-17 | 1.95x |
| 2025-12-16 | 1.95x |
| 2025-12-15 | 1.96x |
| 2025-12-12 | 1.95x |
| 2025-12-11 | 1.95x |
| 2025-12-10 | 1.95x |
| 2025-12-09 | 1.95x |
| 2025-12-08 | 1.95x |
| 2025-12-05 | 1.95x |
| 2025-12-04 | 1.95x |
| 2025-12-03 | 1.95x |
| 2025-12-02 | 1.95x |
| 2025-12-01 | 1.95x |
| 2025-11-28 | 1.95x |
| 2025-11-26 | 1.95x |
| 2025-11-25 | 1.95x |
| 2025-11-24 | 1.95x |
| 2025-11-21 | 1.94x |
| 2025-11-20 | 1.93x |
| 2025-11-19 | 1.93x |
| 2025-11-18 | 1.93x |
| 2025-11-17 | 1.99x |
| 2025-11-14 | 1.99x |
| 2025-11-13 | 1.99x |
| 2025-11-12 | 2.00x |
| 2025-11-11 | 2.00x |
| 2025-11-10 | 1.99x |
| 2025-11-07 | 1.99x |
| 2025-11-06 | 1.99x |
| 2025-11-05 | 1.99x |
| 2025-11-04 | 1.99x |
| 2025-11-03 | 1.99x |
| 2025-10-31 | 1.98x |
| 2025-10-30 | 1.98x |
| 2025-10-29 | 1.98x |
| 2025-10-28 | 1.98x |
| 2025-10-27 | 1.98x |
| 2025-10-24 | 1.98x |
| 2025-10-23 | 1.98x |
| 2025-10-22 | 1.98x |
| 2025-10-21 | 1.98x |
| 2025-10-20 | 1.93x |
| 2025-10-17 | 1.88x |
| 2025-10-16 | 1.84x |
| 2025-10-15 | 1.80x |
| 2025-10-14 | 1.78x |
| 2025-10-13 | 1.77x |
| 2025-10-10 | 1.82x |
| 2025-10-09 | 1.85x |
| 2025-10-08 | 1.84x |
| 2025-10-07 | 1.82x |
| 2025-10-06 | 1.81x |
| 2025-10-03 | 1.84x |
| 2025-10-02 | 1.83x |
| 2025-10-01 | 1.81x |
| 2025-09-30 | 1.82x |
| 2025-09-29 | 1.81x |
| 2025-09-26 | 1.81x |
| 2025-09-25 | 1.77x |
| 2025-09-24 | 1.79x |
| 2025-09-23 | 1.82x |
| 2025-09-22 | 1.81x |
| 2025-09-19 | 1.79x |
| 2025-09-18 | 1.84x |
| 2025-09-17 | 1.84x |
| 2025-09-16 | 1.71x |
| 2025-09-15 | 1.72x |
| 2025-09-12 | 1.74x |
| 2025-09-11 | 1.79x |
| 2025-09-10 | 1.77x |
| 2025-09-09 | 1.80x |
| 2025-09-08 | 1.79x |
| 2025-09-05 | 1.80x |
| 2025-09-04 | 1.79x |
| 2025-09-03 | 1.79x |
| 2025-09-02 | 1.79x |
| 2025-08-29 | 1.81x |
| 2025-08-28 | 1.80x |
| 2025-08-27 | 1.80x |
| 2025-08-26 | 1.80x |
| 2025-08-25 | 1.81x |
| 2025-08-22 | 1.84x |
| 2025-08-21 | 1.81x |
| 2025-08-20 | 1.85x |
| 2025-08-19 | 1.83x |
| 2025-08-18 | 1.81x |
| 2025-08-15 | 1.83x |
| 2025-08-14 | 1.83x |
| 2025-08-13 | 1.86x |
| 2025-08-12 | 1.83x |
| 2025-08-11 | 1.83x |
| 2025-08-08 | 1.83x |
| 2025-08-07 | 1.83x |
| 2025-08-06 | 1.80x |
| 2025-08-05 | 1.83x |
| 2025-08-04 | 1.83x |
| 2025-08-01 | 1.81x |
| 2025-07-31 | 1.80x |
| 2025-07-30 | 1.85x |
| 2025-07-29 | 1.87x |
| 2025-07-28 | 1.86x |
| 2025-07-25 | 1.89x |
| 2025-07-24 | 1.88x |
| 2025-07-23 | 1.87x |
| 2025-07-22 | 1.86x |
| 2025-07-21 | 1.81x |
| 2025-07-18 | 1.82x |
| 2025-07-17 | 1.82x |
| 2025-07-16 | 1.82x |
| 2025-07-15 | 1.80x |
| 2025-07-14 | 1.84x |
| 2025-07-11 | 1.87x |
| 2025-07-10 | 1.90x |
| 2025-07-09 | 1.87x |
| 2025-07-08 | 1.84x |
| 2025-07-07 | 1.83x |
| 2025-07-03 | 1.84x |
| 2025-07-02 | 1.85x |
| 2025-07-01 | 1.86x |
| 2025-06-30 | 1.85x |
| 2025-06-27 | 1.85x |
| 2025-06-26 | 1.85x |
| 2025-06-25 | 1.83x |
| 2025-06-24 | 1.84x |
| 2025-06-23 | 1.83x |
| 2025-06-20 | 1.83x |
| 2025-06-18 | 1.82x |
| 2025-06-17 | 1.82x |
| 2025-06-16 | 1.85x |
| 2025-06-13 | 1.84x |
| 2025-06-12 | 1.85x |
| 2025-06-11 | 1.84x |
| 2025-06-10 | 1.85x |
| 2025-06-09 | 1.83x |
| 2025-06-06 | 1.83x |
| 2025-06-05 | 1.80x |
| 2025-06-04 | 1.78x |
| 2025-06-03 | 1.79x |
| 2025-06-02 | 1.77x |
| 2025-05-30 | 1.77x |
| 2025-05-29 | 1.79x |
| 2025-05-28 | 1.81x |
| 2025-05-27 | 1.77x |
| 2025-05-23 | 1.56x |
| 2025-05-22 | 1.57x |
| 2025-05-21 | 1.58x |
| 2025-05-20 | 1.62x |
| 2025-05-19 | 1.62x |
| 2025-05-16 | 1.63x |
| 2025-05-15 | 1.60x |
| 2025-05-14 | 1.59x |
| 2025-05-13 | 1.64x |
| 2025-05-12 | 1.68x |
| 2025-05-09 | 1.63x |
| 2025-05-08 | 1.61x |
| 2025-05-07 | 1.59x |
| 2025-05-06 | 1.53x |
| 2025-05-05 | 1.52x |
| 2025-05-02 | 1.56x |
| 2025-05-01 | 1.61x |
| 2025-04-30 | 1.63x |
| 2025-04-29 | 1.64x |
| 2025-04-28 | 1.63x |
| 2025-04-25 | 1.63x |
| 2025-04-24 | 1.64x |
| 2025-04-23 | 1.63x |
| 2025-04-22 | 1.63x |
| 2025-04-21 | 1.60x |
| 2025-04-17 | 1.62x |
| 2025-04-16 | 1.59x |
| 2025-04-15 | 1.63x |
| 2025-04-14 | 1.65x |
| 2025-04-11 | 1.63x |
| 2025-04-10 | 1.61x |
| 2025-04-09 | 1.66x |
| 2025-04-08 | 1.64x |
| 2025-04-07 | 1.72x |
| 2025-04-04 | 1.71x |
| 2025-04-03 | 1.73x |
| 2025-04-02 | 1.70x |
| 2025-04-01 | 1.72x |
| 2025-03-31 | 1.73x |
| 2025-03-28 | 1.72x |
| 2025-03-27 | 1.74x |
| 2025-03-26 | 1.72x |
| 2025-03-25 | 1.70x |
Showing the most recent 260 of 5,030 data points. The chart above shows the full history.
Related Metrics
About Hologic, Inc.
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul Malenchini